Back to Search Start Over

Fluorescent ligands for dopamine D 2 /D 3 receptors.

Authors :
Allikalt A
Purkayastha N
Flad K
Schmidt MF
Tabor A
Gmeiner P
Hübner H
Weikert D
Source :
Scientific reports [Sci Rep] 2020 Dec 14; Vol. 10 (1), pp. 21842. Date of Electronic Publication: 2020 Dec 14.
Publication Year :
2020

Abstract

Fluorescent ligands are versatile tools for the study of G protein-coupled receptors. Depending on the fluorophore, they can be used for a range of different applications, including fluorescence microscopy and bioluminescence or fluorescence resonance energy transfer (BRET or FRET) assays. Starting from phenylpiperazines and indanylamines, privileged scaffolds for dopamine D <subscript>2</subscript> -like receptors, we developed dansyl-labeled fluorescent ligands that are well accommodated in the binding pockets of D <subscript>2</subscript> and D <subscript>3</subscript> receptors. These receptors are the target proteins for the therapy for several neurologic and psychiatric disorders, including Parkinson's disease and schizophrenia. The dansyl-labeled ligands exhibit binding affinities up to 0.44 nM and 0.29 nM at D <subscript>2</subscript> R and D <subscript>3</subscript> R, respectively. When the dansyl label was exchanged for sterically more demanding xanthene or cyanine dyes, fluorescent ligands 10a-c retained excellent binding properties and, as expected from their indanylamine pharmacophore, acted as agonists at D <subscript>2</subscript> R. While the Cy3B-labeled ligand 10b was used to visualize D <subscript>2</subscript> R and D <subscript>3</subscript> R on the surface of living cells by total internal reflection microscopy, ligand 10a comprising a rhodamine label showed excellent properties in a NanoBRET binding assay at D <subscript>3</subscript> R.

Details

Language :
English
ISSN :
2045-2322
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
Scientific reports
Publication Type :
Academic Journal
Accession number :
33318558
Full Text :
https://doi.org/10.1038/s41598-020-78827-9